Health Reform Home Stretch: Revised Senate Bill Includes Clinical Trial Coverage Mandate
This article was originally published in The Pink Sheet Daily
Manager's amendment passes key procedural hurdle.
You may also be interested in...
Biopharmas could win grants equivalent to half of their research expenses in 2009 and 2010, plus apply for a slice of the $500 million in new R&D funding available in areas of high medical need, courtesy of the health reform package
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.